118 related articles for article (PubMed ID: 23760432)
1. Urine melatonin levels are inversely associated with sarcopenia in postmenopausal women.
Lee JY; Kim JH; Lee DC
Menopause; 2014 Jan; 21(1):39-44. PubMed ID: 23760432
[TBL] [Abstract][Full Text] [Related]
2. Urine 6-sulfatoxymelatonin levels are inversely associated with arterial stiffness in post-menopausal women.
Lee JY; Lee DC
Maturitas; 2014 Jun; 78(2):117-22. PubMed ID: 24780409
[TBL] [Abstract][Full Text] [Related]
3. Association of urinary levels of 6-sulfatoxymelatonin (aMT6s) with prevalent and incident hypertension.
Pérez-Caraballo AM; Ma Y; Ockene JK; Reeves KW; Balasubramanian R; Stanczyk FZ; Allison MA; Chen C; Wang L; Manson JE; Sturgeon SR
Chronobiol Int; 2018 Aug; 35(8):1115-1121. PubMed ID: 29750588
[TBL] [Abstract][Full Text] [Related]
4. Association of Urinary 6-Sulfatoxymelatonin (aMT6s) Levels and Objective and Subjective Sleep Measures in Older Men: The MrOS Sleep Study.
Saksvik-Lehouillier I; Harrison SL; Marshall LM; Tranah GJ; Ensrud K; Ancoli-Israel S; Clemons A; Redline S; Stone KL; Schernhammer ES;
J Gerontol A Biol Sci Med Sci; 2015 Dec; 70(12):1569-77. PubMed ID: 26265731
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility over 5 years of measurements of 6-sulphatoxymelatonin in urine samples from postmenopausal women.
Travis RC; Allen NE; Peeters PH; van Noord PA; Key TJ
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):806-8. PubMed ID: 12917214
[TBL] [Abstract][Full Text] [Related]
6. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women.
Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Sieri S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
J Natl Cancer Inst; 2008 Jun; 100(12):898-905. PubMed ID: 18544743
[TBL] [Abstract][Full Text] [Related]
7. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status.
Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704
[No Abstract] [Full Text] [Related]
8. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels.
Schernhammer ES; Kroenke CH; Dowsett M; Folkerd E; Hankinson SE
J Pineal Res; 2006 Mar; 40(2):116-24. PubMed ID: 16441548
[TBL] [Abstract][Full Text] [Related]
9. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort.
Schernhammer ES; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):74-9. PubMed ID: 19124483
[TBL] [Abstract][Full Text] [Related]
10. Association of vegetables and fruits consumption with sarcopenia in older adults: the Fourth Korea National Health and Nutrition Examination Survey.
Kim J; Lee Y; Kye S; Chung YS; Kim KM
Age Ageing; 2015 Jan; 44(1):96-102. PubMed ID: 24646604
[TBL] [Abstract][Full Text] [Related]
11. Muscle strength and quality are associated with severity of menopausal symptoms in peri- and post-menopausal women.
Lee JY; Lee DC
Maturitas; 2013 Sep; 76(1):88-94. PubMed ID: 23838172
[TBL] [Abstract][Full Text] [Related]
12. Association between leukocyte count and sarcopenia in postmenopausal women: The Korean National Health and Nutrition Examination Survey.
Chung TH; Shim JY; Lee YJ
Maturitas; 2016 Feb; 84():89-93. PubMed ID: 26675924
[TBL] [Abstract][Full Text] [Related]
13. Urinary Melatonin in Relation to Breast Cancer Risk: Nested Case-Control Analysis in the DOM Study and Meta-analysis of Prospective Studies.
Wong ATY; Fensom GK; Key TJ; Onland-Moret NC; Tong TYN; Travis RC
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):97-103. PubMed ID: 33144281
[TBL] [Abstract][Full Text] [Related]
14. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort.
Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Grioni S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):729-37. PubMed ID: 20200429
[TBL] [Abstract][Full Text] [Related]
15. Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.
Rosen R; Hu DN; Perez V; Tai K; Yu GP; Chen M; Tone P; McCormick SA; Walsh J
Mol Vis; 2009 Aug; 15():1673-9. PubMed ID: 19710945
[TBL] [Abstract][Full Text] [Related]
16. Serotonin and melatonin secretion in postmenopausal women with eating disorders.
Chojnacki C; Walecka-Kapica E; Błońska A; Winczyk K; Stępień A; Chojnacki J
Endokrynol Pol; 2016; 67(3):299-304. PubMed ID: 27364373
[TBL] [Abstract][Full Text] [Related]
17. Melatonin and breast cancer: a prospective study.
Travis RC; Allen DS; Fentiman IS; Key TJ
J Natl Cancer Inst; 2004 Mar; 96(6):475-82. PubMed ID: 15026473
[TBL] [Abstract][Full Text] [Related]
18. Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II.
Brown SB; Hankinson SE; Eliassen AH; Reeves KW; Qian J; Arcaro KF; Wegrzyn LR; Willett WC; Schernhammer ES
Am J Epidemiol; 2015 Feb; 181(3):155-62. PubMed ID: 25587174
[TBL] [Abstract][Full Text] [Related]
19. Melatonin and female hormone secretion in postmenopausal overweight women.
Walecka-Kapica E; Chojnacki J; Stępień A; Wachowska-Kelly P; Klupińska G; Chojnacki C
Int J Mol Sci; 2015 Jan; 16(1):1030-42. PubMed ID: 25569084
[TBL] [Abstract][Full Text] [Related]
20. Melatonin and the Charlson Comorbidity Index (CCI): the Treviso Longeva (Trelong) study.
Gallucci M; Flores-Obando R; Mazzuco S; Ongaro F; Di Giorgi E; Boldrini P; Durante E; Frigato A; Albani D; Forloni G; Zanardo A; Siculi M; Caberlotto L; Taioli E
Int J Biol Markers; 2014 Sep; 29(3):e253-60. PubMed ID: 24557791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
